DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE

Company Overview - LIXTE Biotechnology Holdings Inc. is a clinical-stage pharmaceutical company focused on developing and commercializing cancer therapies, particularly through its lead compound LB-100, which is a first-in-class PP2A inhibitor [9][10] - The company is pioneering a new treatment paradigm in cancer biology known as activation lethality, supported by a comprehensive patent portfolio [10] - LIXTE is also developing electronically controlled proton therapy systems through its subsidiary, Liora Technologies Europe Ltd., with its flagship technology, the LiGHT System, believed to offer significant advantages in tumor treatment [11] Event Details - The inaugural Good Health: Mind, Body & Soul Summit, sponsored by LIXTE, will take place on February 19, 2026, at Morehouse College in Atlanta, focusing on health equity for Black men and families [2][3] - The event is inspired by the music and legacy of De La Soul, aiming to connect health, culture, and science to promote wellness [4][5] - The Summit will feature discussions on various health topics, including cancer, heart disease, mental health, and intergenerational wellness, bringing together health experts, artists, and community leaders [5]

Lixte Biotechnology-DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE - Reportify